Dren Bio Strengthens Leadership Team With Appointment of Amit Mehta, Ph.D., As Chief Operating Officer and Chief Business Officer
Dren Bio Strengthens Leadership Team With Appointment of Amit Mehta, Ph.D., As Chief Operating Officer and Chief Business Officer
10/30/23, 12:23 PM
Location
foster cityIndustry
biotechnology
Position
chief business officer
chief operating officer
Dren Bio, Inc. a clinical-stage biopharmaceutical company developing antibody therapeutics for cancer, autoimmune and other serious diseases, today announced the expansion of its leadership team with the appointment of Amit Mehta, Ph.D., as the Company’s Chief Operating Officer and Chief Business Officer
Company Info
Location
321 grunion court
foster city, california, united states
Additional Info
DR-0201 is a targeted bispecific myeloid cell engager. It is designed for deep B-cell depletion, particularly in immunology applications. This therapy represents a potential treatment option for diseases like lupus. The acquisition strengthens Sanofi's early pipeline.